Xencor, Inc. reported its third quarter and nine-month 2025 financial results on November 5, showing net loss reductions to US$6.03 million and US$85.27 million, respectively, both significantly lower ...

Returned to Profitability with Net Income of $0.2M Third Consecutive Quarter of Positive Adjusted EBITDA Revenue Rises to $5.9M, with AI ...

Due to Tesla's innovation and diversification, 24/7 Wall St. sees strong upside potential for the stock by the end of the ...

Diamonds can be natural or lab-grown, and understanding the difference helps consumers make an informed choice.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

NEW YORK and TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN, OTCID: ITHUF), which owns, operates, and partners with regulated cannabis ...

Very strong order momentum, with third quarter order intake up 33% year-over-yearOrder backlog increased by another 6% since June 2025, supporting 2026 growth ambitionsGroup net sales of $471m, up 3% ...

NOT FOR DISSEMINATION IN THE U.S. OR THROUGH U.S. NEWSWIRES/ CALGARY, AB, Nov. 14, 2025 /CNW/ - Highwood Asset Management Ltd ...

BITF's bold pivot into HPC/AI faces mounting costs, execution risks and valuation concerns that cloud its growth outlook.

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, today ...

Thursday, November 13, 2025 at 5 p.m. ET Need a quote from a Motley Fool analyst? Email [email protected] Net loss attributed to ...